Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care center.

Bommannan, Karthik; Arumugam, Jhansi Rani; Radhakrishnan, Venkatraman; Kalaiyarasi, Jayachandran Perumal; Mehra, Nikita; Sagar, Tenali Gnana; Sundersingh, Shirley

Bommannan, Karthik; Arumugam, Jhansi Rani; Radhakrishnan, Venkatraman; Kalaiyarasi, Jayachandran Perumal; Mehra, Nikita; Sagar, Tenali Gnana; Sundersingh, Shirley.

Afiliação

Bommannan K; Cancer Institute (W.I.A.), Adyar, Chennai, India. Electronic address: bkkb87@gmail.com.
Arumugam JR; Cancer Institute (W.I.A.), Adyar, Chennai, India.
Radhakrishnan V; Cancer Institute (W.I.A.), Adyar, Chennai, India.
Kalaiyarasi JP; Cancer Institute (W.I.A.), Adyar, Chennai, India.
Mehra N; Cancer Institute (W.I.A.), Adyar, Chennai, India.
Sagar TG; Cancer Institute (W.I.A.), Adyar, Chennai, India.
Sundersingh S; Cancer Institute (W.I.A.), Adyar, Chennai, India.

Hematol Transfus Cell Ther ; 44(2): 143-150, 2022.

Article em En | MEDLINE | ID: mdl-33526373

Palavras-chave

CD56 positive precursor B lineage acute lymphoblastic leukemia; CD7 positive precursor B lineage acute lymphoblastic leukemia; Precursor B lineage acute lymphoblastic leukemia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Hematol Transfus Cell Ther Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google